6-Bromoindirubin-3′-oxime derivatives are highly active colistin adjuvants against <i>Klebsiella pneumoniae</i>
作者:Haoting Li、Anne E. Mattingly、Richard D. Smith、Roberta J. Melander、Robert K. Ernst、Christian Melander
DOI:10.1039/d2md00370h
日期:——
Multidrug resistant (MDR) bacterial infections have become increasingly common, leading clinicians to rely on last-resort antibiotics such as colistin.